Respiratory Complications of Rapidly Progressive Neuromuscular Syndromes: Guillain-Barré Syndrome and Myasthenia Gravis

 

 Buy Article Permissions and Reprints

ABSTRACT

Neuromuscular respiratory failure is a common complication of both the Guillain-Barré syndrome and myasthenia gravis. Several key pathophysiological mechanisms contribute to the spiral of respiratory insufficiency in these diseases, including inspiratory, expiratory, and bulbar muscle weakness. It is important to identify patients with impending respiratory failure early to avoid emergency intubations. Several clinical features and bedside pulmonary function tests (PFTs) are useful in guiding decisions about intubation. Weaning is initiated when respiratory muscles have recovered sufficiently, and again, PFT criteria are helpful. Intravenous immunoglobulin and plasmapheresis are the cornerstones of specific therapy for both illnesses when complicated by respiratory failure. Mortality and morbidity are dramatically increased by respiratory failure and are mainly due to associated medical complications. Optimal outcomes depend on avoidance of these and prompt implementation of immunomodulatory therapy.

REFERENCES

• 1 Kurtzke J F. Epidemiology of MG.  Adv Neurol . 1978;  19 545
  PubMedGoogle Scholar
• 2 Osserman K E, Genkins G. Studies in myasthenia gravis: review of twenty year experience in over 1200 patients.  Mt Sinai J Med . 1971;  38 497
  PubMedGoogle Scholar
• 3 Thomas C E, Mayer S A, Gungor Y. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation.  Neurology . 1997;  48 1253-1260
  CrossrefPubMedGoogle Scholar
• 4 Berrouschot J, Baumann I, Kalischewski P. Therapy of myasthenic crisis.  Crit Care Med . 1997;  25 1228-1235
  CrossrefPubMedGoogle Scholar
• 5 Huges R A, Ress J H. Clinical and epidemiologic features of Guillain Barré syndrome.  J Infect Dis . 1997;  S92-S99
  PubMedGoogle Scholar
• 6 Ropper A H. Severe acute Guillain-Barré syndrome.  Neurology . 1986;  36 429-432
  PubMedGoogle Scholar
• 7 Ropper A H. The Guillain-Barré syndrome.  N Engl J Med . 1992;  326 1130-1135
  CrossrefPubMedGoogle Scholar
• 8 Teitelbaum J S, Borel C O. Respiratory dysfunction in Guillian Barré syndrome.  Clin Chest Med . 1994;  15 705-714
  PubMedGoogle Scholar
• 9 Lawn N D, Flecther D D, Henderson R D, Wolter T D, Wijdicks E FM. Anticipating mechanical ventilation in Guillain-Barré syndrome.  Arch Neurol . 2001;  58 893-898
  CrossrefPubMedGoogle Scholar
• 10 Fink M E. Treatment of critically ill patients with myasthenia gravis. In: Ropper AH, ed. Neurological and Neurosurgical Intensive care 3rd ed. New York: Raven Press 1993: 351-362
  Google Scholar
• 11 Heffner J E. Timing tracheostomy: calendar watching or individualization of care.  Chest . 1998;  114 361-363
  PubMedGoogle Scholar
• 12 Maziak D E, Meade M O, Todd T RJ. The timing of tracheostomy: a systematic review.  Chest . 1998;  114 605-609
  CrossrefPubMedGoogle Scholar
• 13 Stock M C, Woodward C G, Shapiro B A. Perioperative complications of elective tracheostomy in critically ill patients.  Crit Care Med . 1986;  14 861-863
  CrossrefPubMedGoogle Scholar
• 14 Lawn N D, Wijdicks E FM. Tracheostomy in Guillain-Barré syndrome.  Muscle Nerve . 1999;  22 1058-1062
  PubMedGoogle Scholar
• 15 The Plasma Exchange/Sandoglobin Guillain-Barré Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997 349: 225-230
  Google Scholar
• 16 van der Meche G F, Schmitz P I, the Dutch Guillain Barré study group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome.  N Engl J Med . 1992;  326 1123-1129
  PubMedGoogle Scholar
• 17 French Cooperative Group on Plasma Exchange in Guillain Barré Syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 1987 22: 753-761
  Google Scholar
• 18 The Guillain-Barré Syndrome Study Group. Plasmapharesis and acute Guillian-Barré syndrome.  Neurology . 1985;  35 1096-1104
  PubMedGoogle Scholar
• 19 Couriel D, Weinstien R. Complications of therapeutic plasma exchange: a recent assessment.  J Clin Apheresis . 1994;  9 1-5
  PubMedGoogle Scholar
• 20 Wijdiks E FM. Guillain Barré syndrome. In: Wijdiks EFM, ed. The Clinical Practice of Critical Care Neurology New York: Lippincott-Raven Publishers 1997: 290-306
  Google Scholar
• 21 Kornfeld P, Ambinder E P, Mittag T. Plasmapheresis in refractory generalized myasthenia gravis.  Arch Neurol . 1981;  38 478-481
  PubMedGoogle Scholar
• 22 Antozzi C, Gemma M, Regi B. A short plasma exchange protocol is effective in severe myasthenia gravis.  J Neurol . 1991;  238 103-107
  CrossrefPubMedGoogle Scholar
• 23 Thorlacius S, Aarli J A, Jacobson H. Plasma exchange in myasthenia gravis: clinical effect.  Acta Neurol Scand . 1985;  72 464-468
  PubMedGoogle Scholar
• 24 Stricker R B, Kwiatkowska B J, Habis J A. Myasthenic crises: response to plasmapheresis following failure of intravenous gammaglobulin.  Arch Neurol . 1993;  50 837-840
  CrossrefPubMedGoogle Scholar
• 25 Arsura E L, Bick A, Brunner N G, Namba T, Grob D. High-dose intravenous immunoglobulin in the management of myasthenia gravis.  Arch Intern Med . 1986;  146 1365-1368
  CrossrefPubMedGoogle Scholar
• 26 Evoli A, Palmisani M T, Bartoccioni E, Padua L, Tonali P. High-dose intravenous immunoglobulin in myasthenia gravis.  Ital J Neurol Sci . 1993;  14 233-237
  PubMedGoogle Scholar
• 27 Jongen J L, van Doorn A P, van der Meche G F. High-dose intravenous immunoglobulin therapy for myasthenia gravis.  J Neurol . 1998;  245 26-31
  PubMedGoogle Scholar
• 28 Howard Jr F J. Intravenous immunoglobulin for the treatment of acquired myasthenia gravis.  Neurology . 1998;  51(6 suppl 5) S30-S36
  PubMedGoogle Scholar
• 29 Mayer S A, Thomas C E. Therapy of myasthenic crisis.  Crit Care Med . 1998;  26 1136-1137
  PubMedGoogle Scholar
• 30 Winer J B, Hughes R AC. Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome.  Q J Med . 1988;  257 735-739
  PubMedGoogle Scholar
• 31 de Jager E A, Sluiter H J. Clinical signs in severe Guillain-Barré syndrome: analysis of 63 patients.  J Neurol Sci . 1991;  104 143-150
  CrossrefPubMedGoogle Scholar
• 32 Roubenoff R A, Borel C O, Hanley D F. Hypermetabolism and hypercatbolism in Guillain-Barré syndrome.  J Parenter Enteral Nutr . 1992;  16 464-472
  PubMedGoogle Scholar
• 33 Moulin D E, Hagen N, Feasby T E, Amireh R, Hahn A. Pain in Guillain-Barré síndrome.  Neurology . 1997;  48 328-331
  CrossrefPubMedGoogle Scholar
• 34 Tripathi M, Kaushik S. Carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit.  Crit Care Med . 2000;  28 655-658
  PubMedGoogle Scholar
• 35 Chaleha J A. Pearls and pitfalls in the intensive care management of Guillain Barré syndrome.  Seminars in Neurology . 2001;  21 399-405
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Tether J E. Management of myasthenic and cholinergic crisis.  Am J Med . 1955;  19 740-742
  PubMedGoogle Scholar
• 37 Cohen M S, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death.  Ann NY Acad Sci . 1981;  377 670-677
  PubMedGoogle Scholar
• 38 Selecky P A, Ziment I. Prolonged respirator support for the treatment of intractable myasthenia gravis.  Chest . 1974;  65 207-209
  PubMedGoogle Scholar
• 39 Cornblath D R, Mellits E D, Griffin J W. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.  Ann Neurol . 1988;  23 354-359
  CrossrefPubMedGoogle Scholar
• 40 Winer J B, Hughes R AC, Greenwood R J, Perkin G D, Healy M JR. Prognosis in Guillain-Barré syndrome.  Lancet . 1985;  1 1202-1203
  PubMedGoogle Scholar
• 41 Winer J B, Hughes R AC, Osmond C. A prospective of acute idiopathic neuropathy: clinical features and their prognostic value.  J Neurol Neurosurg Psychiatry . 1988;  51 605-612
  CrossrefPubMedGoogle Scholar
• 42 Fletcher D D, Lawn N D, Wolter T D, Wijdicks E FM. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation.  Neurology . 2000;  54 2311-2315
  PubMedGoogle Scholar
• 43 Mayer S A. Intensive care of myasthenic patient.  Neurology . 1997;  48 S70-S75
  CrossrefPubMedGoogle Scholar